Michael Screen
Impact in
-
- Multiple Myeloma Research and Treatments
-
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- RNA Research and Splicing
- Protein Degradation and Inhibitors
- Glycosylation and Glycoproteins Research
Papers in
-
- RNA Research and Splicing 4
- Ubiquitin and proteasome pathways 3
- RNA modifications and cancer 2
- RNA and protein synthesis mechanisms 2
- Glycosylation and Glycoproteins Research 1
- Oncology 3
- Peptidase Inhibition and Analysis 2
- Co-authors
- Martin Turner (6 shared papers)Sondra L. Downey-Kopyscinski (3 shared papers)Alexei F. Kisselev (3 shared papers)Daniel J. Hodson (2 shared papers)Alexandre A. Pletnev (2 shared papers)Martijn Verdoes (2 shared papers)Herman S. Overkleeft (2 shared papers)Omar Amir (1 shared paper)
- Journals
- PLoS ONE (1 paper)Life Science Alliance (1 paper)Blood (1 paper)Science Immunology (1 paper)Nature Immunology (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Michael Screen
9 papers receiving 435 citations
Peers
Comparison fields: 5 of 53
- Hematology 60
- Molecular Biology 365
- Oncology 127
- Cancer Research 63
- Immunology 54
Countries citing papers authored by Michael Screen
This map shows the geographic impact of Michael Screen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Screen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Screen more than expected).
Fields of papers citing papers by Michael Screen
This network shows the impact of papers produced by Michael Screen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Screen. The network helps show where Michael Screen may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Screen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 143 | |
| 2 | 2018 | 65 | |
| 3 | 2013 | 55 | |
| 4 | 2010 | 54 | |
| 5 | 2019 | 45 | |
| 6 | 2013 | 45 | |
| 7 | 2023 | 15 | |
| 8 | 2022 | 14 | |
| 9 | 2023 | 3 | |
| 10 | 2025 | 0 |
About Michael Screen
Michael Screen is a scholar working on Molecular Biology, Oncology, Immunology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 10 papers that have together received 439 indexed citations. Recurring topics across this work include RNA Research and Splicing (4 papers), Ubiquitin and proteasome pathways (3 papers), T-cell and B-cell Immunology (2 papers), Peptidase Inhibition and Analysis (2 papers), Immune Cell Function and Interaction (2 papers), RNA modifications and cancer (2 papers), RNA and protein synthesis mechanisms (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Hematology (60 citations), Molecular Biology (365 citations), Oncology (127 citations), Cancer Research (63 citations) and Immunology (54 citations). Michael Screen has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Martin Turner, Sondra L. Downey-Kopyscinski, Alexei F. Kisselev, Daniel J. Hodson, Alexandre A. Pletnev, Martijn Verdoes, Herman S. Overkleeft, Omar Amir, Dennis L. Wright and Robert Tokhunts. Their work appears in journals such as PLoS ONE, Life Science Alliance, Blood, Science Immunology and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.